Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Institute for Human Genetics and Genomic Medicine, |
RCV002280604 | SCV002568084 | uncertain significance | Combined oxidative phosphorylation deficiency 28 | 2022-08-10 | criteria provided, single submitter | clinical testing | The detected change is not listed in control collectives (dbSNP151, gnomAD as of 08/10/2022). Bioinformatically, the change is classified as "probably disease-causing" (PolyPhen2, Mutation Taster, SIFT, CADDphred 26.2). It is located in the protein domains "IPR018108" and "Mitochondrial carrier domain superfamily" of the corresponding protein and the nucleotide or amino acid in question is highly conserved. Based on the current state of knowledge, the variant can be classified as a “variant of uncertrain clinical significance” (ACMG criteria). It was observed in trans with the variant NM_173471.4:c.719G>T, which was also classified as "variant of uncertain clinical significance". |